跳至主要内容
临床试验/NCT00337675
NCT00337675已完成3 期

A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years

Organon and Co0 个研究点目标入组 1,771 人开始时间: 2006年10月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
1,771
主要终点
Number of Asthma Episodes Culminating in Asthma Attack Over the 1-year Treatment Period

研究概览

简要总结

This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients aged 6 months to 5 years with episodic (periodic) asthma

排除标准

  • Patients who are not in otherwise good health
  • Patients who have persistent asthma (continual asthma symptoms)

研究组 & 干预措施

Arm 1: drug + episodic supplemental placebo

Active Comparator

Montelukast once a day (qd) + episode driven supplemental placebo qd for 12 days for a 52-wk treatment period

干预措施: montelukast sodium (Drug)

Arm 2: placebo comparator + episodic supplemental drug

Active Comparator

Placebo qd + episode driven supplemental Montelukast qd for 12 days for a 52-wk treatment period

干预措施: montelukast sodium (Drug)

结局指标

主要结局

Number of Asthma Episodes Culminating in Asthma Attack Over the 1-year Treatment Period

时间窗: 1-year treatment period

The rate per year of asthma episodes culminating in an asthma attack for each of the 3 treatment groups. Asthma attacks were defined as respiratory symptoms requiring healthcare resource utilization (HRU), which comprised unscheduled visits to a physician or emergency department, treatment with corticosteroids (oral, rectal, or inhaled), or hospitalization. Each day during an episode, the patient's legal guardian recorded all the HRU that was required specifically for breathing problems.

次要结局

  • Daily Average of Wheeze and Difficulty Breathing in the 3 Days Prior to Start of an Asthma Attack Within an Asthma Episode(1 Year)
  • Daily Average of the Mean Symptom Scores (Wheeze, Difficulty Breathing, Interference With Activity, and Daytime Cough) Assessed Over the 12-day Treatment Period of Asthma Episodes(1 Year)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Intermittent and Daily Dosing for Episodic... | 临床试验